S&P 500

5.631,22

0,00%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ARDX

Ardelyx (ARDX)

Ardelyx Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

<< Previous 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
16/03/2020	14h00	PR Newswire (US)	Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors	NASDAQ:ARDX	Ardelyx Inc
10/03/2020	21h44	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ARDX	Ardelyx Inc
06/03/2020	22h08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ARDX	Ardelyx Inc
06/03/2020	22h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
06/03/2020	22h02	PR Newswire (US)	Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights	NASDAQ:ARDX	Ardelyx Inc
26/02/2020	14h00	PR Newswire (US)	Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference	NASDAQ:ARDX	Ardelyx Inc
20/02/2020	23h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
20/02/2020	22h36	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:ARDX	Ardelyx Inc
19/02/2020	14h00	PR Newswire (US)	Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
14/02/2020	23h09	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARDX	Ardelyx Inc
14/02/2020	19h53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARDX	Ardelyx Inc
13/02/2020	18h24	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARDX	Ardelyx Inc
12/02/2020	22h12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARDX	Ardelyx Inc
12/02/2020	12h05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ARDX	Ardelyx Inc
05/12/2019	05h32	PR Newswire (US)	Ardelyx Announces Pricing of Upsized Public Offering of Common Stock	NASDAQ:ARDX	Ardelyx Inc
04/12/2019	22h56	PR Newswire (US)	Ardelyx Announces Proposed Public Offering of Common Stock	NASDAQ:ARDX	Ardelyx Inc
03/12/2019	13h25	PR Newswire (US)	Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialys...	NASDAQ:ARDX	Ardelyx Inc
02/12/2019	22h01	PR Newswire (US)	Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study	NASDAQ:ARDX	Ardelyx Inc
26/11/2019	22h00	PR Newswire (US)	Ardelyx to Present at the Piper Jaffray 31st Annual Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
26/11/2019	00h00	PR Newswire (US)	Ardelyx and Kyowa Kirin Expand Partnership with Two Additional Agreements	NASDAQ:ARDX	Ardelyx Inc
06/11/2019	22h26	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARDX	Ardelyx Inc
06/11/2019	22h19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
06/11/2019	22h05	PR Newswire (US)	Ardelyx Announces Presentation at Kidney Week 2019	NASDAQ:ARDX	Ardelyx Inc
06/11/2019	22h02	PR Newswire (US)	Ardelyx Reports Third Quarter 2019 Financial Results and Recent Highlights	NASDAQ:ARDX	Ardelyx Inc
10/10/2019	22h00	PR Newswire (US)	Ardelyx to Host Analyst Day in New York	NASDAQ:ARDX	Ardelyx Inc
08/10/2019	23h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
27/09/2019	18h07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARDX	Ardelyx Inc
17/09/2019	22h01	PR Newswire (US)	Ardelyx to Present at the Ladenburg Thalmann 2019 Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
13/09/2019	14h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
12/09/2019	21h13	PR Newswire (US)	Ardelyx Receives FDA Approval for IBSRELA® (Tenapanor), an NHE3 Sodium Transport Inhibitor, for the Treatment of Irritable B...	NASDAQ:ARDX	Ardelyx Inc